BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22095555)

  • 1. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect.
    Yang MD; Chiang YM; Higashiyama R; Asahina K; Mann DA; Mann J; Wang CC; Tsukamoto H
    Hepatology; 2012 Apr; 55(4):1271-81. PubMed ID: 22095555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.
    Zhu NL; Wang J; Tsukamoto H
    J Biol Chem; 2010 Oct; 285(40):30463-71. PubMed ID: 20663865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
    Zhu NL; Asahina K; Wang J; Ueno A; Lazaro R; Miyaoka Y; Miyajima A; Tsukamoto H
    J Biol Chem; 2012 Mar; 287(13):10355-10367. PubMed ID: 22298767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.
    Tsai TH; Shih SC; Ho TC; Ma HI; Liu MY; Chen SL; Tsao YP
    PLoS One; 2014; 9(4):e95443. PubMed ID: 24763086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosmarinic acid inhibits proliferation and induces apoptosis of hepatic stellate cells.
    Zhang JJ; Wang YL; Feng XB; Song XD; Liu WB
    Biol Pharm Bull; 2011; 34(3):343-8. PubMed ID: 21372382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
    Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
    FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation.
    Zhou Q; Guan W; Qiao H; Cheng Y; Li Z; Zhai X; Zhou Y
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2367-77. PubMed ID: 25305367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
    Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.
    Zhang F; Kong D; Lu Y; Zheng S
    Cell Mol Life Sci; 2013 Jan; 70(2):259-76. PubMed ID: 22699820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
    Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
    J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.
    Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H
    PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARgamma agonist KR62776.
    Bae MA; Rhee SD; Jung WH; Ahn JH; Song BJ; Cheon HG
    Arch Pharm Res; 2010 Mar; 33(3):433-42. PubMed ID: 20361309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
    Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
    Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.
    Mann J; Chu DC; Maxwell A; Oakley F; Zhu NL; Tsukamoto H; Mann DA
    Gastroenterology; 2010 Feb; 138(2):705-14, 714.e1-4. PubMed ID: 19843474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system.
    Lu C; Zou Y; Liu Y; Niu Y
    Toxicol Appl Pharmacol; 2017 Mar; 318():69-78. PubMed ID: 28115189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme Oxygenase-1 Inhibits the Proliferation of Hepatic Stellate Cells by Activating PPAR
    Yang H; Zhang L; Chen J; Zhang X; Zhao Z; Zhao L
    Comput Math Methods Med; 2022; 2022():8920861. PubMed ID: 35047060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis.
    Li GS; Jiang WL; Tian JW; Qu GW; Zhu HB; Fu FH
    Phytomedicine; 2010 Mar; 17(3-4):282-8. PubMed ID: 19524418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
    Liu X; Xu J; Rosenthal S; Zhang LJ; McCubbin R; Meshgin N; Shang L; Koyama Y; Ma HY; Sharma S; Heinz S; Glass CK; Benner C; Brenner DA; Kisseleva T
    Gastroenterology; 2020 May; 158(6):1728-1744.e14. PubMed ID: 31982409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.